Skip to main content

Disclosure Search

Home
/
Filings
/
[docId]

Guide|Excel Add-in|Learning Guide|About This Site|Privacy Policy|Terms of Use|Contact

Guide Excel Add-in Learning Guide About This Site Privacy Policy Terms of Use Contact

Search and track Japanese corporate disclosures in one place.

Built from publicly available information. This site is not operated or endorsed by the relevant public institutions.

© 2026 Disclosure Search · Time2Analyze

Disclosure filing

半期報告書－第23期(2026/01/01－2026/12/31)

8/7/2026, 2:39:00 PM

EDINET Code: E30058

Document Additional Information

Document Type

Semi-annual securities report

Form

043A00

Ordinance

010

Period

01/01/2026 ~ 12/31/2026

Accounting Standards

Japan GAAP

Modified Period

06/30/2025 ~ 06/30/2026

Structured Data

Related Entities

Issuer Company

Oncolys BioPharma Inc.

Securities Code: 4588

Japan Corporate Number: 4010401053237

Industry: Pharmaceutical

Location: 港区虎ノ門４－１－２８虎ノ門タワーズオフィス１０階

Downloadable File Types

Data

PDF

CSV